Viewing Study NCT05338957


Ignite Creation Date: 2025-12-24 @ 6:51 PM
Ignite Modification Date: 2026-01-15 @ 2:48 PM
Study NCT ID: NCT05338957
Status: UNKNOWN
Last Update Posted: 2022-12-01
First Post: 2022-04-15
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of MRG002 in the Treatment of Patients With HER2-expressed Advanced Malignant Solid Tumors.
Sponsor: Shanghai Miracogen Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module